LAM
HELP

Lewis Asset Management’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Lewis Asset Management’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,946
Closed -$82.1K – 187
2025
Q3 		$82.1K Buy
+13,946
New +$98.8K 0.03% 186
2024
Q3 		– Sell
-7,947
Closed -$81.8K – 132
2024
Q2 		$81.8K Buy
7,947
+526
+7% +$6.89K 0.06% 116
2024
Q1 		$117K Hold
7,421
– – 0.1% 116
2023
Q4 		$116K Buy
+7,421
New +$138K 0.11% 107

Other funds holding HELP

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Lewis Asset Management's HELP Position: Q4 2025 in Review

Lewis Asset Management sold out of Helus Pharma Inc. Common Stock (HELP) in Q4 2025, closing a stake of 13,946 shares — an estimated $82.1K sold.

Lewis Asset Management first reported a position in HELP in Q4 2023 and held it in 4 quarters. The position peaked at $117K in Q1 2024. 80 funds tracked by Wall St. Rank hold HELP as of Q4 2025.

  • Lewis Asset Management reported no remaining Helus Pharma Inc. Common Stock position as of Q4 2025 after selling out during the quarter.
  • Lewis Asset Management sold 13,946 Helus Pharma Inc. Common Stock shares in Q4 2025, an estimated $82.1K.
  • Lewis Asset Management first reported a position in Helus Pharma Inc. Common Stock in Q4 2023 and held it in 4 quarters.
  • Lewis Asset Management's Helus Pharma Inc. Common Stock position peaked at $117K in Q1 2024.
  • 80 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q4 2025.

Based on Lewis Asset Management's 13F filing for Q4 2025, filed 15 Jan 2026.